Doctor profile · Federal record
Dr. MUHAMMAD KHAN, M.D.
Neurology Physician (CMS: NEUROLOGY) · Neurology Physician · SUGAR LAND, TX
- NPI 1538233200
- Accepts Medicare
- 27 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2743 IMPERIA DR STE 101
SUGAR LAND, TX 774798988
(281) 494-6387
Credentials & registration
- NPI registered
- November 2006 — 20 yrs on file
- Profile last updated
- June 12, 2024
- Year of graduation
- 1999 — 27 yrs since
- Specialty taxonomy
- 2084N0400X — NUCC code
- State licenses (2)
- Texas #N0162 · Nebraska #23745
- Medicaid (2)
- TX #202188303 · TX #202188302
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1538233200. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,083
Distinct HCPCS
9
Medicare allowed
$119,355
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 406 | 211 | $123 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 231 | 129 | $76 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 195 | 190 | $125 | |
95819 |
Measurement of brain wave activity (eeg), awake and asleep | 86 | 80 | $54 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 61 | 61 | $159 | |
95822 |
Measurement of brain wave activity (eeg), in coma or asleep | 55 | 37 | $54 | |
95813 |
Measurement of brain wave activity (eeg), 61-119 minutes | 20 | 20 | $408 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 18 | 14 | $86 | |
95816 |
Measurement of brain wave activity (eeg), awake and drowsy | 11 | 11 | $54 |
In context: peer comparison
Among 9 peers in this city , average services per provider: 331. This provider delivers 3.3× the peer median.Open Payments
Industry payments received
All-time total
$846
Transactions
38
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| UCB, Inc. | 12 | $201.67 | |
| ABBVIE INC. | 4 | $94.84 | |
| SK Life Science, Inc. | 3 | $89.65 | |
| Eisai Inc. | 3 | $64.46 | |
| Aucta Pharmaceuticals, Inc. | 4 | $60.73 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50.70 | |
| HARMONY BIOSCIENCES LLC | 2 | $44.72 | |
| Neurelis, Inc. | 1 | $42.03 | |
| Inspire Medical Systems, Inc. | 1 | $32.48 | |
| Novartis Pharmaceuticals Corporation | 1 | $28.63 | |
| Azurity Pharmaceuticals, Inc. | 1 | $23.52 | |
| PFIZER INC. | 1 | $21.94 | |
| JAZZ PHARMACEUTICALS INC. | 1 | $20.95 | |
| Grifols USA, LLC | 1 | $20.01 | |
| Lundbeck LLC | 1 | $19.45 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
720
Patients
161
Total drug cost
$223,709
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levetiracetam | Generic | 123 | 39 | $5,363 |
| Gabapentin | Generic | 119 | 39 | $2,702 |
| Lacosamide | Generic | 94 | 16 | $30,350 |
| Donepezil Hcl | Generic | 48 | 16 | $793 |
| Memantine Hcl | Generic | 47 | 17 | $1,231 |
| Carbamazepine | Generic | 41 | 12 | $5,514 |
| Divalproex Sodium Er (Divalproex Sodium) | Brand | 34 | 0 | $2,287 |
| Phenobarbital | Generic | 34 | 0 | $1,214 |
| Clonazepam | Generic | 31 | 0 | $596 |
| Pregabalin | Generic | 29 | 11 | $1,048 |